The invention relates to thienopyrimidines of formula (I) and the physiologically tolerable salts thereof, wherein R<1>, R<2> and X have the designation cited in patent claim 1. Said compounds exhibit a phosphodiesterase V inhibition and can be used to treat illnesses of the cardiovascular system. They can also be used for treating, and/or as therapy for, potency problems.
